Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Molecular Partners AG: Strategic Partnership Expansions and Financial Overview

Mar 08, 2025•over 1 year ago

Contract Type

partnership

BiotechnologyTherapeuticsBiopharma

Description

Molecular Partners AG highlighted strategic partnership expansions with Orano Med to include ten programs, strengthening its position in the radiopharmaceuticals sector. The company also reported strong financial metrics for 2024 showing a robust cash reserve of CHF 149 million, expected to support operations until 2027, despite operating losses.

Company Information

Company

Molecular Partners AG

About

Molecular Partners AG is a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics.

Predictive Intelligence
Strategic

ML-powered predictions for Molecular Partners AG's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.